Prognostic significance of progesterone receptor levels in luminal-like Her2-early breast cancer patients. A retrospective single cancer center analysis

被引:0
|
作者
Diana, A. [1 ]
Carlino, F. [1 ]
Franzese, E. [1 ]
Centonze, S. [1 ]
Guerrera, L. P. [1 ]
Perrone, A. [1 ]
De Vita, F. [1 ]
Ciardiello, F. [1 ]
Orditura, M. [1 ]
机构
[1] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
247P
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Luminal (Her2 negative) prognostic index and survival of breast cancer patients
    Chen, Xuesong
    Cong, Yingying
    Pan, Lihua
    Jiang, Ying
    Meng, Qingwei
    Sun, Lichun
    Pang, Hui
    Zhao, Yanbin
    Dong, Xiaoqun
    Cai, Li
    CANCER EPIDEMIOLOGY, 2014, 38 (03) : 286 - 290
  • [32] The prognostic significance of Ki67 and progesterone receptor; could they really have prognostic importance in early breast cancer with estrogen receptor positive, HER-2 negative?
    Choi, Soon Bo
    Park, Jung Min
    Ahn, Jee Hyun
    Go, Jieon
    Kim, Jeeye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Seho
    CANCER RESEARCH, 2022, 82 (04)
  • [33] Heterogeneity and prognostic characteristics of HER2-low breast cancer: A retrospective analysis of patients with HER2-negative metastatic breast cancer
    Lv, Huimin
    Yan, Min
    Zhang, Mengwei
    Niu, Limin
    Zeng, Huiai
    Sun, Huihui
    Zhao, Shengnan
    Wang, Jing
    CANCER RESEARCH, 2024, 84 (09)
  • [34] A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
    Gong, Gyungyub
    Kwon, Mi Jeong
    Han, Jinil
    Lee, Hee Jin
    Lee, Se Kyung
    Lee, Jeong Eon
    Lee, Seon-Heui
    Park, Sarah
    Choi, Jong-Sun
    Cho, Soo Youn
    Ahn, Sei Hyun
    Lee, Jong Won
    Cho, Sang Rae
    Moon, Youngho
    Nam, Byung-Ho
    Nam, Seok Jin
    Choi, Yoon-La
    Shin, Young Kee
    SCIENTIFIC REPORTS, 2017, 7
  • [35] First line treatment in patients with luminal-like metastatic breast cancer: a propensity score-matched analysis
    Bonotto, M.
    Gerratana, L.
    Arpino, G.
    Di Maio, M.
    De Angelis, C.
    Iacono, D.
    Cinausero, M.
    Milano, M.
    Gargiulo, P.
    Fontanella, C.
    Bozza, C.
    Moroso, S.
    Minisini, M.
    Mansutti, M.
    Fasola, G.
    De Placido, S.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 8 - 8
  • [36] PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
    Rajc, Jasmina
    Frohlich, Irena
    Mrcela, Milanka
    Tomas, Ilijan
    Flam, Josipa
    ACTA CLINICA CROATICA, 2018, 57 (03) : 425 - 433
  • [37] Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis
    Sanpaolo, Pietro
    Barbieri, Viviana
    Pedicini, Piernicola
    Fusco, Vincenzo
    MEDICAL ONCOLOGY, 2012, 29 (02) : 459 - 465
  • [38] Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis
    Pietro Sanpaolo
    Viviana Barbieri
    Piernicola Pedicini
    Vincenzo Fusco
    Medical Oncology, 2012, 29 : 459 - 465
  • [39] PROGNOSTIC SIGNIFICANCE OF PROGESTERONE RECEPTOR-POSITIVE TUMOR CELLS WITHIN IMMUNOHISTOCHEMICALLY-DEFINED LUMINAL A BREAST CANCER
    Prat, A.
    Cheang, M. C.
    Martin, M.
    Carrasco, E.
    Caballero, R.
    Tyldesley, S.
    Gelmon, K.
    Bernard, P. S.
    Nielsen, T. O.
    Perou, C. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 17 - 18
  • [40] Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis
    Bonotto, Marta
    Gerratana, Lorenzo
    Di Maio, Massimo
    De Angelis, Carmine
    Cinausero, Marika
    Moroso, Stefano
    Milano, Monica
    Stanzione, Brigida
    Gargiulo, Piera
    Iacono, Donatella
    Minisini, Alessandro Marco
    Mansutti, Mauro
    Fasola, Gianpiero
    De Placido, Sabino
    Arpino, Grazia
    Puglisi, Fabio
    BREAST, 2017, 31 : 114 - 120